Cargando…
Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56
Breast cancer ranks no. 1 in women cancer worldwide, while 60–70% are estrogen receptor alpha positive. The estrogen selective modulators, such as tamoxifen, become the effective drugs for controlling ER alpha breast cancer progression. However, tamoxifen resistance will develop during long-time tre...
Autores principales: | Xue, Min, Zhang, Kai, Mu, Kun, Xu, Juntao, Yang, Huijie, Liu, Yun, Wang, Beibei, Wang, Zhonghao, Li, Zhongbo, Kong, Qiong, Li, Xiumin, Wang, Hui, Zhu, Jian, Zhuang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473003/ https://www.ncbi.nlm.nih.gov/pubmed/31000690 http://dx.doi.org/10.1038/s41389-019-0139-x |
Ejemplares similares
-
Origin and Diversification of TRIM Ubiquitin Ligases
por: Marín, Ignacio
Publicado: (2012) -
Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
por: Wang, Zhonghao, et al.
Publicado: (2020) -
TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression
por: Zhuang, Ting, et al.
Publicado: (2022) -
Structural insights into the TRIM family of ubiquitin E3 ligases
por: Li, Yang, et al.
Publicado: (2014) -
TRIM32 is an E3 ubiquitin ligase for dysbindin
por: Locke, Matthew, et al.
Publicado: (2009)